Riley Wyberg

ID: 1b826635-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Approves Celltrion’s Denosumab Biosimilars

Big Molecule Watch · March 6, 2025

Regulatory Updates on Samsung’s Denosumab Biosimilars

Big Molecule Watch · February 17, 2025

Regulatory and Commercial Updates on Bio-Thera’s BAT2506 (golimumab)

Big Molecule Watch · February 11, 2025

FDA Approves Celltrion’s AVTOZMA (tocilizumab-anoh)

Big Molecule Watch · February 3, 2025

Teva Announces New Biosimilar Deals

Big Molecule Watch · January 27, 2025